
    
      This is a double masked, prospective, randomized study in which five groups of approximately
      30 patients meeting the eligibility criteria will be randomly assigned in a balanced ratio to
      receive a series of intravitreal (IVT) injections of VEGF Trap into the study eye at 4- or 12
      -week intervals over a 12-week period.

      After Week 12, patients will be evaluated every 4 weeks. Patients will remain on study or may
      be eligible to enter a long-term extension study, in which they will continue to receive VEGF
      Trap.
    
  